The first head-to-head randomised controlled trial comparing Suliqua®▼ (insulin glargine 100 units m/L and lixisenatide) to a premixed insulin.
Virtual Event: Unlocking the Premix Paradox
September - November 2021 - 20 min sessions & 10 min Q&A
Join an Expert Review of SoliMix, the new clinical data for Suliqua. Register for one of the 32 sessions where a Health Care Professional of your choice will present to you:
- SoliMix clinical study and share the results of this study
- How this data might impact clinical choices and the relevance for your patients with Type 2 Diabetes with an HbA1c >9%
What to expect?
During this virtual event, a SoliMix Expert will give a short presentation of 20 minutes, followed by a 10 minute Q&A session. Scroll down to find the dates and experts available.
Who can join?
This event is for you, if you are an HCP who manages patients who are:
- People with Type 2 Diabetes > 9% HbA1c (75mmol/mol)
- People with Type 2 Diabetes you might consider a premixed insulin for
- People with Type 2 Diabetes on 2 or more oral therapies not reaching target HbA1c levels
- People with Type 2 Diabetes on basal insulin not reaching target HbA1c levels
Suliqua is indicated for the treatment of adults with insufficiently controlled Type 2 diabetes mellitus, to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without SGLT-2 inhibitors.
Dates - September
|Thursday 2nd September||13:00 - 13:30||Dr Abdul-Wahid Mohammad||Zoom|
|19:00 - 19:30||Dr Abdul-Wahid Mohammad||Zoom|
|Friday 3rd September||13:00 - 13:30||Dr Amar Ali||Teams|
|Tuesday 7th September||19:00 - 19:30||Professor David Hopkins||Zoom|
|Wednesday 8th September||15:00 - 15:30||Gareth Thomas||Teams|
|Thursday 9th September||19:00 - 19:30||Professor Tom Barber||Teams|
|Friday 10th September||13:00 - 13:30||Dr Amar Ali||Zoom|
|Friday 17th September||13:00 - 13:30||Dr Rashmi Kaushal||Zoom|
|Tuesday 21st September||13:00 - 13:30
||Dr Abdul Lakhdar||Teams|
|Wednesday 22nd September
||19:00 - 19:30||Dr Uazman Alam||Zoom|
|Thursday 23rd September||15:00 - 15:30
||Professor Iskander Idris||Zoom|
|Friday 24th September||13:00 - 13:30||Professor Tom Barber||Teams|
|Tuesday 28th September||19:00 - 19:30||Dr Abdul Lakhdar||Teams|
|Wednesday 29th September
||13:00 - 13:30
||Professor Babara McGowan||Zoom|
Dates - October and November
Adverse events should be reported. For UK healthcare professionals only: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to the Sanofi drug safety department on 0800 0902 314. Alternatively, send via email to UKfirstname.lastname@example.org. Prescribing information will be available at the meeting.